Skip to main content

View full-text article in PMC

. 2003 Mar;10(2):308–314. doi: 10.1128/CDLI.10.2.308-314.2003

TABLE 2.

MMP-9, TIMP-1, and MMP-2 enzyme and protein levels

Diagnosis (no. of patients)	MMP-9									TIMP-1			MMP-2
	Enzyme (pixel count)			Protein (ng/ml)			Activity (ng/ml)			Protein (ng/ml)			Enzyme (pixel count)
	Mean	Median	Range	Mean	Median	Range	Mean	Median	Range	Mean	Median	Range	Mean	Median	Range
Complete KD (31)
Acute phase	114,754^a^,^b^,^c	83,843	12,630-29,511	1,147^a^,^b^,^c	645	30-4,206	11	7	1-122	1,321^a^,^b^,^c	1,218	152-2,515	38,989^b	35,591	2,328-108,604
Convalescent phase	29,523	16,927	2,250-113,540	193	129	26-1,013	9	9	1.2-20.7	651	400	120-2,500	43,122	3,209	6,755-153,121
Incomplete KD (7)
Acute phase	95,222^a	76,512	22,047-253,990	1,271^a^,^b^,^c	1,193	252-2,630	8.4^b	8	2.5-15.2	1,487^a^,^b^,^c	1,534	585-2,493	20,483	12,698	2,628-72,738
Convalescent phase	21,118	9,118	4,017-58,511	109	84	31-322	16	15	7.4-31.1	412	330	222-926	54,383	49,604	8,174-101,345
Febrile (9)	54,948	29,693	1,507-190,606	428	141	62-2,005	9	8	2.3-16.7	599	228	55-2,498	10,154	11,068	1,154-17,759
Afebrile (17)	25,071	15,258	3,062-268,922	110	55	10-808	16	16	1.5-33.8	552	439	106-2,824	34,662	33,109	3,282-76,749

^a

P < 0.05, acute versus convalescent phase.

^b

P < 0.05, acute phase versus febrile.

^c

P < 0.05, acute phase versus afebrile.